Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Immuron Limited

< Previous 1 2 Next >
Immuron Letter to Shareholders: Projects Update
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Travelan® highest sales in history
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Travelan® continued strong sales growth
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Announces Travelan® Clinical Trial Update
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Travelan® continued strong sales growth
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron announces record Travelan® sales globally, Australia and USA
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron requests pre-IND meeting for IMM-529 with FDA filing
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron CEO Steven Lydeamore to present at Peak Sky High
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Board Changes
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Limited to Present at the Emerging Growth Conference
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Director Resignation
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron to host Live Virtual Event
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Travelan® sales continued strong growth
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Presentation Australian Biologics Festival 2024
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron achieves record Travelan® sales
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron achieves record half yearly Travelan® sales
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
Immuron Clinical Trials Update
From Immuron Limited
Via GlobeNewswire
Tickers ASX:IMC IMRN
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.